Prognostic relevance of minimal residual disease in colorectal cancer

被引：31

作者：

Bork, Ulrich ^{[1
]}

Gruetzmann, Robert ^{[1
]}

Rahbari, Nuh N. ^{[1
]}

Schoelch, Sebastian ^{[1
]}

Distler, Marius ^{[1
]}

Reissfelder, Christoph ^{[1
]}

Koch, Moritz ^{[1
]}

Weitz, Juergen ^{[1
]}

机构：

[1] Tech Univ Dresden, Dept GI Thorac & Vasc Surg, Univ Hosp Dresden, D-01307 Dresden, Germany

来源：

WORLD JOURNAL OF GASTROENTEROLOGY | 2014年 / 20卷 / 30期

关键词：

Colorectal cancer; Circulating tumor cells; Disseminated tumor cells; Isolated tumor cells; Micrometastases; Occult disease; Minimal residual disease; CIRCULATING TUMOR-CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; METASTATIC COLON-CANCER; PERIPHERAL-BLOOD; BREAST-CANCER; LYMPH-NODES; BONE-MARROW; MODEL; MICE; DISSEMINATION;

D O I：

10.3748/wjg.v20.i30.10296

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Presence of occult minimal residual disease in patients with colorectal cancer (CRC) has a strong prognostic impact on survival. Minimal residual disease plays a major role in disease relapse and formation of metastases in CRC. Analysis of circulating tumor cells (CTC) in the blood is increasingly used in clinical practice for disease monitoring of CRC patients. In this review article the role of CTC, disseminated tumor cells (DTC) in the bone marrow and micrometastases and isolated tumor cells (ITC) in the lymph nodes will be discussed, including literature published until September 2013. Occult disease is a strong prognostic marker for patient survival in CRC and defined by the presence of CTC in the blood, DTC in the bone marrow and/or micrometastases and ITC in the lymph nodes. Minimal residual disease could be used in the future to identify patient groups at risk, who might benefit from individualized treatment options. (C) 2014 Baishideng Publishing Group Inc. All rights reserved.

引用

页码：10296 / 10304

页数：9

共 50 条

[1] Prognostic relevance of minimal residual disease in colorectal cancer
Ulrich Bork
Robert Grützmann
Nuh N Rahbari
Sebastian Schlch
Marius Distler
Christoph Reissfelder
Moritz Koch
Jürgen Weitz
World Journal of Gastroenterology, 2014, (30) : 10296 - 10304
[2] Diagnosis and clinical relevance of minimal residual disease in patients with colorectal cancer
Doeberitz, MV
Koch, M
Weitz, J
Herfarth, C
ZENTRALBLATT FUR CHIRURGIE, 2000, 125 : 15 - 19
[3] Minimal residual epithelial cancer: Diagnostic approaches and prognostic relevance
Pantel, K
Braun, S
Passlick, B
Schlimok, G
MINIMAL RESIDUAL EPITHELIAL CANCER: DIAGNOSTIC APPROACHES AND PROGNOSTIC RELEVANCE, 1996, 30 (03): : 43 - 60
[4] Detection and significance of minimal residual disease in colorectal cancer
Merrie, AEH
Yun, K
van Rij, AM
McCall, JL
HISTOLOGY AND HISTOPATHOLOGY, 1999, 14 (02) : 561 - 569
[5] Minimal residual disease in breast cancer: Diagnosis and biological relevance
不详
PATHOLOGY RESEARCH AND PRACTICE, 2005, 201 (03) : 211 - 211
[6] Clinical relevance and prognostic value of minimal residual disease in multiple myeloma.
Terragna, C
Martinelli, G
Rossi, M
Bonifazi, F
Soverini, S
Amabile, M
Giannini, B
Ottaviani, E
Buonamici, S
Zamagni, E
Cellini, C
Tosi, P
Tura, S
Cavo, M
Baccarani, M
BLOOD, 2002, 100 (11) : 599A - 599A
[7] Prognostic Relevance of Minimal Residual Disease Detection in Paediatric Acute Myeloid Leukemia
Chopra, A.
Mehta, P.
Soni, S.
Bakhshi, S.
Kumar, R.
PEDIATRIC BLOOD & CANCER, 2016, 63 : S188 - S188
[8] Minimal residual cancer: Diagnostic approaches, prognostic relevance, biology and antibody therapy
Pantel, K
TUMORDIAGNOSTIK & THERAPIE, 1999, 20 (05) : 131 - 134
[9] Molecular detection of minimal residual disease in colorectal and breast cancer
Liefers, GJ
Tollenaar, RAEM
Cleton-Jansen, AM
HISTOPATHOLOGY, 1999, 34 (05) : 385 - 390
[10] Peritoneal minimal residual disease in colorectal cancer: mechanisms, prevention, and treatment
Ceelen, Wim P.
Bracke, Marc E.
LANCET ONCOLOGY, 2009, 10 (01): : 72 - 79

← 1 2 3 4 5 →